About Manisha Chatterjee
Since she was young, Manisha has had a strong interest in the stock market. She majored in Economics in college and has a passion for writing, which has led to her career as a research analyst.
Manisha’s goal is to help individual investors succeed in the stock market. She uses her knowledge in fundamental analysis to evaluate companies and determine if they are worthwhile investments.
Recent Articles By Manisha Chatterjee
After Plunging More Than 10% Last Week, is Pinterest a Buy?
Pinterest (PINS) is an established company in the social media space that is known for its virtual Pinboard style, which attracts millions of users worldwide. However, the company’s stock price fell sharply following an unfavorable comment by a Cleveland Research analyst. So, let’s find out if PINS is set for a rebound or if it faces more trouble down the road.
A Top Agriculture Stock to Add to Your Portfolio
Canada-based agricultural chemicals company Nutrien (NTR) has generated significant returns by leveraging its diverse portfolio of products and services in the agriculture space. Because the industry appears to be on the path to recovery from the pandemic-driven recession, with increasing crop prices, we think it’s wise to bet on the stock now. Let’s take a closer look at NTR.
Workhorse Plunges More Than 40% in 2021: More Downside Left?
The price of Workhorse’s (WKHS) shares has been declining since late February when the company lost out on a Next Generation Delivery Vehicle (NGDV) contract with the United States Postal Service (USPS). So, let’s find out if this was only a bump in the road for the EV and drone system company or if it is expected to continue going downhill from here. Read on.
Is PDC Energy a Great Energy Stock Right Now?
PDC Energy (PDCE) has been growing organically and inorganically over the past few months. And given rising oil prices, we think the company should continue to increase its revenues. So, it could be wise to bet on the stock now. Read on
Illumina is a Buy Even After the Recent Sell-Off
Illumina (ILMN) has grown significantly over the past few months on huge demand for its products and services in the genetic analysis space. And although its share price has dipped since the FTC announced that it will challenge ILMN’s proposed acquisition of Grail, the stock is expected to regain its rally soon given the company's numerous strategic alliances. Read on for details.
Is Titan Medical a Good Medical Equipment Stock to Add to Your Portfolio?
Toronto-based Titan Medical (TMDI) is a small company in the growing medical robotic equipment space. The company is developing its Enos system—a potentially new standard of care in robotic single access surgery. But should investors scoop up its shares at this stage? Let’s find out.
Will Zoom Video Keep Losing in 2021?
Zoom (ZM) became synonymous with remote conferencing last year as COVID-19 lock-down restrictions made the service a group-communications go-to. The stock thus enjoyed immense investor attention. However, given the extensive vaccination drives so far this year, many organizations may now be considering a resumption of physical conferences at the expense of virtual ones. Also, major tech companies are now offering similar services. So, the question is, will ZM be able to regain its momentum this year?
Should Roku Be in Your Portfolio?
Roku (ROKU) has been capitalizing on the trend in which consumers are embracing TV streaming platforms at the expense of traditional linear TV. The company has made numerous strategic acquisitions over the past few months as part of its expansion efforts. However, is its pricey valuation justified by its near-term prospects? Let’s find out.
Here’s Why Biotech Investors Should Buy Regeneron Pharmaceuticals Now
With an array of FDA-approved products in hand and several candidates in the pipeline, Regeneron Pharmaceuticals (REGN) has delivered big returns over the past few years. We think it’s wise to buy the stock now simply because it has plenty of upside and is trading at a discount to its peers. Read on.